Instituto de Pesquisa, HCor-Hospital do Coração - São Paulo (SP), Brasil.
Instituto de Cardiologia do Distrito Federal, Fundação Universitária de Cardiologia - Brasília (DF), Brasil.
Rev Bras Ter Intensiva. 2020 Oct-Dec;32(4):493-505. doi: 10.5935/0103-507X.20200081.
To report the statistical analysis plan (first version) for the Balanced Solutions versus Saline in Intensive Care Study (BaSICS).
BaSICS is a multicenter factorial randomized controlled trial that will assess the effects of Plasma-Lyte 148 versus 0.9% saline as the fluid of choice in critically ill patients, as well as the effects of a slow (333mL/h) versus rapid (999mL/h) infusion speed during fluid challenges, on important patient outcomes. The fluid type will be blinded for investigators, patients and the analyses. No blinding will be possible for the infusion speed for the investigators, but all analyses will be kept blinded during the analysis procedure.
BaSICS will have 90-day mortality as its primary endpoint, which will be tested using mixed-effects Cox proportional hazard models, considering sites as a random variable (frailty models) adjusted for age, organ dysfunction and admission type. Important secondary endpoints include renal replacement therapy up to 90 days, acute renal failure, organ dysfunction at days 3 and 7, and mechanical ventilation-free days within 28 days.
This manuscript provides details on the first version of the statistical analysis plan for the BaSICS trial and will guide the study's analysis when follow-up is finished.
报告平衡溶液与生理盐水在重症监护中的应用研究(BaSICS)的统计分析计划(第一版)。
BaSICS 是一项多中心、两因素随机对照试验,旨在评估在重症患者中选择使用 Plasma-Lyte 148 与 0.9%生理盐水作为首选液体的效果,以及在液体冲击时采用较慢(333mL/h)与较快(999mL/h)输注速度的效果,对重要的患者结局的影响。研究者、患者和分析将对液体类型设盲。对于研究者而言,输注速度无法设盲,但在分析过程中,所有分析将保持盲法。
BaSICS 将以 90 天死亡率为主要终点,使用混合效应 Cox 比例风险模型进行检验,考虑到站点作为一个随机变量(脆弱性模型),调整年龄、器官功能障碍和入院类型。重要的次要终点包括 90 天内的肾脏替代治疗、急性肾衰竭、第 3 天和第 7 天的器官功能障碍,以及 28 天内的无机械通气天数。
本文提供了 BaSICS 试验第一版统计分析计划的详细信息,将指导研究完成后进行分析。